The authors studied the effect of different therapeutical regimens on the growth of children suffering from asthma. These patients were subdivided into four groups of ten patients according to their therapeutic regimens: Group A = ketotifene (1 mg, two times/day), Group B = diproprionate beclomethasone + salbuthamol (100 + 200 mcg, 3 times/day), Group C = ketotifene + diproprionate beclomethasone, Group D = disodiumcromoglycate (20 mg, 3 times/day). The patients were followed for at least 1 year. Our study has shown that all the children treated with the four different regimens had a normal growth and growth velocity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

group ketotifene
8
times/day group
8
diproprionate beclomethasone
8
long-term therapy
4
therapy childhood
4
childhood asthma
4
asthma clinical
4
clinical auxological
4
auxological effects
4
effects authors
4

Similar Publications

Primary human mast cells (MC) obtained through culturing of blood-derived MC progenitors are the preferred model for the study of MRGPRX2- IgE-mediated MC activation. In order to assess the impact of culture conditions on functional MRGPRX2 expression, we cultured CD34-enriched PBMC from peripheral whole blood (PB) and buffy coat (BC) samples in MethoCult medium containing stem cell factor (SCF) and interleukin (IL)-3, modified through variations in seeding density and adding or withholding IL-6, IL-9 and fetal bovine serum (FBS). Functional expression of MRGPRX2 was assessed after 4 weeks via flow cytometry.

View Article and Find Full Text PDF

Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas.

Mol Cancer Ther

November 2024

Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.

Article Synopsis
  • Sarcomas are rare and complex cancers originating in soft tissues or bones, making their treatment difficult due to a challenging tumor microenvironment (TME) that limits drug delivery.
  • A study tested the drug ketotifen in combination with advanced chemotherapy and immunotherapy techniques in mouse models, which showed that ketotifen improved the TME by reducing tumor stiffness and increasing blood flow, leading to better treatment outcomes.
  • This treatment combination also enhanced immune response by increasing the presence of effective T-cells and altering macrophage activity, suggesting a promising approach for improving therapeutic efficacy in sarcoma patients.
View Article and Find Full Text PDF

Intestinal ischemia/reperfusion (I/R) injury is a serious condition that causes intestinal dysfunction and can be fatal. Previous research has shown that toll-like receptor 4 (TLR4) inhibitors have a protective effect against this injury. This study aimed to investigate the protective effects of TLR4 inhibitors, specifically cyclobenzaprine, ketotifen, amitriptyline, and naltrexone, in rats with intestinal (I/R) injury.

View Article and Find Full Text PDF

Background And Objective: Mast cells have been implicated in abdominal pain-associated disorders of gut-brain interaction, such as functional dyspepsia. As such, ketotifen, a second-generation antihistamine and mast cell stabilizer, could represent a viable treatment option in these conditions. The primary aim of the current pilot study was to assess clinical response to ketotifen and assess pharmacokinetics in youth with functional dyspepsia.

View Article and Find Full Text PDF
Article Synopsis
  • This study looked at how a treatment called electroacupuncture (EA) can help rats with a diarrhea-related tummy problem known as irritable bowel syndrome (IBS-D).
  • The researchers tested this treatment by checking how many loose stools the rats had and how sensitive their tummies were when poked.
  • The results showed that EA helped the rats by making their loose stools less frequent and reducing inflammation in their intestines, which means it might help protect their tummy lining.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!